Aurora Cannabis Exports Dried Cannabis Flower and Oils to Australia for Novel Nose-to-Brain Drug Delivery Research by PreveCeutical
March 13, 2018 08:00 ET
|
PreveCeutical Medical Inc.
EDMONTON, Alberta and VANCOUVER, British Columbia, March 13, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – Aurora Cannabis Inc. (“Aurora”) (TSX:ACB) (OTCQB:ACBFF) (Frankfurt:21P) (WKN:A1C4WM) and...
Zealand Pharma 2017 full-year results in line with guidance - considerable progress in the clinical portfolio
March 07, 2018 09:00 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No. 8 / 2018 ...
PreveCeutical Announces Appointment of Dr. Maher Khaled as Director of International Operations
February 26, 2018 09:30 ET
|
PreveCeutical Medical Inc.
VANCOUVER, British Columbia, Feb. 26, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE: PREV)(OTCQB:PRVCF)(FSE:18H), announces the...
Zealand Pharma and UniQuest collaborate to develop novel drug candidates for gastrointestinal diseases
February 20, 2018 03:08 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No. 04 / 2018 ...
NetworkNewsWire Announces Publication on Innovative Approaches in Non-Addictive Analgesics
February 02, 2018 08:30 ET
|
NetworkNewsWire
NEW YORK, Feb. 02, 2018 (GLOBE NEWSWIRE) -- via NetworkWire — NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring...
PreveCeutical Signs Research and Option Agreement with UniQuest Pty Limited for Development of Non-Addictive Analgesic Peptides
January 30, 2018 09:30 ET
|
PreveCeutical Medical Inc.
VANCOUVER, British Columbia, Jan. 30, 2018 (GLOBE NEWSWIRE) -- via NetworkWire -- PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) (OTCQB:PRVCF) (FSE:18H), announces that,...
PreveCeutical Medical Inc. Receives Coverage from Crystal Equity Research
January 11, 2018 16:00 ET
|
NetworkNewsWire
NEW YORK, Jan. 11, 2018 (GLOBE NEWSWIRE) -- NetworkNewsWire announces that Crystal Equity Research has published an initial report on PreveCeutical Medical Inc. (CSE:PREV) (OTCQB:PRVCF) (FSE:18H)....
PreveCeutical™ Medical Inc. Signs Letter of Intent with UniQuest Pty Limited for Research & Development Program Engineering Peptide Therapeutics for Non-Addictive Analgesics
August 08, 2017 03:05 ET
|
PreveCeutical Medical Inc
VANCOUVER, British Columbia, Aug. 08, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) (FSE:18H) announces that on August 7, 2017, the Company signed...
UPDATE - Streetwise Reports Examines How One Multifaceted Biotech Company Began Trading on Canadian Securities Exchange
July 17, 2017 15:07 ET
|
Streetwise Reports
SAN FRANCISCO, CA--(Marketwired - July 17, 2017) - A Vancouver-based biotech firm that aims to become the first preventative medicine company commenced trading on the Canadian Securities Exchange...
Streetwise Reports Examines How One Multifaceted Biotech Company Began Trading on Canadian Securities Exchange
July 17, 2017 08:45 ET
|
Streetwise Reports
SAN FRANCISCO, CA--(Marketwired - July 17, 2017) - A Vancouver-based biotech firm that aims to become the first preventative medicine company commenced trading on the Canadian Securities Exchange...